Bipolar Disorder: 1. Risk for injury related to manic hyperactivity. 3. Risk for injury related to lithium toxicity. 2. Risk for self-directed or other-directed violence related to Acute Agitation in Schizophrenia: 4. Risk for injury related to adverse effects of mood-stabilizing 5. Risk for activity intolerance related to side effects of ASENAPINE● Schizophrenia:Schizophrenia:^468 5 mg twice daily. The safety of doses above 10 mg twice daily with food. Dose increments may be made at 2-day intervals 10 mg twice daily has not been evaluated in clinical trials.up to 80 mg twice daily. daily if there are adverse effects. The safety of doses above 10 mg twice daily. The dose can be decreased to 5 mg twice 2 hours or 20 mg every 4 hours. Maximum dosage: 40 mg/day. has not been evaluated in clinical trials. as needed up to 40 mg/day. May be given as 10 mg every TO ALL MOOD-STABILIZING DRUGSNURSING DIAGNOSES RELATED (^) drowsiness and dizziness.environment.unresolved anger turned inward on the self or outward on the drugs.^ ●^ PSYCHOTROPIC MEDICATIONS^ (Saphris)^ Adults: Adults: Adults: PO: PO: PO: Usual starting and target dose: Initial dose: 20 mg twice daily Recommended initial dose:^ Adults: IM: 10 to 20 mg
barré
(Barré)
#1